Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma.
Wu D, Zhang C, Liao G, Leng K, Dong B, Yu Y, Tai H, Huang L, Luo F, Zhang B, et al. Cell Mol Biol Lett. 2022 Nov 26; 27(1):105. Epub 2022 Nov 26.